Analysis & Opinions
January 31, 2013
Repros Therapeutics Inc. (RPRX) recently announced that results from the first pivotal study (ZA-301) of Androxal ...
January 25, 2013
Biogen Idec (BIIB) recently announced positive top-line data on its phase III multiple sclerosis candidate, ...
January 23, 2013
Abbott Labs (ABT) reported fourth quarter 2012 earnings of $1.51 per share, a penny ahead of the Zacks Consensus ...
January 09, 2013
Abbott Laboratories (ABT) recently announced that its Absorb Bioresorbable Vascular Scaffold (BVS) device has moved ...
January 04, 2013
January 2 was the first day of trading for the pharmaceutical spin-off.
January 03, 2013
Abbott Laboratories (ABT) recently announced that the company has separated its research-based pharmaceuticals ...